Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases

Código QR

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases

Guardado en:

Detalles Bibliográficos
Autores principales:	Yunqiu Jiang, Sunny S Po, Faris Amil, Tarun W Dasari
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/e5fe5c7645ac466fa5222508f2a378af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Idiopathic Left Ventricular Tachycardia Originating in the Left Posterior Fascicle
por: Hongwu Chen, et al.
Publicado: (2020)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Shahnam Sharif, et al.
Publicado: (2021)

Low serum corin levels predict end-organ damage in patients with hypertensive crisis
por: Burcu Genç Yavuz1, et al.
Publicado: (2021)

Non‐invasive isthmus identification of complex arrhythmias in congenital heart disease
por: Levio Quinto, et al.
Publicado: (2021)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias
por: Chen Wei, et al.
Publicado: (2020)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
por: Amelia Carro, et al.
Publicado: (2019)

The Association Between Psoriasis and Cardiovascular Diseases
por: Ahmed Zwain, et al.
Publicado: (2021)

Effects of aerospace environments on the cardiovascular system
por: Erdinç Ercan
Publicado: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
por: Aniket S Rali, et al.
Publicado: (2021)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Jiang Li, et al.
Publicado: (2021)

Novel Non-invasive Fractional Flow Reserve from Coronary CT Angiography to Determine Ischemic Coronary Stenosis
por: Lavanya Cherukuri, et al.
Publicado: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
por: Pensée Wu, et al.
Publicado: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Level is Related to Clinical Prognosis In Patients with Acute Atherosclerosis-related Ischemic Stroke
por: Xiaoli Yang MMed, et al.
Publicado: (2021)

24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
por: Hector Ventura
Publicado: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021)

Pacemaker and Defibrillator Implantation and Programming in Patients with Deep Brain Stimulation
por: Mark Elliott, et al.
Publicado: (2019)

Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris
por: Sascha Beck, et al.
Publicado: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Ernest Spitzer, et al.
Publicado: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: BMY Cheung, et al.
Publicado: (2020)